Expression levels of IL-27 and IL-17 in multiple myeloma patients: A higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival-Reference-Cited by-同舟云学术

Expression levels of IL-27 and IL-17 in multiple myeloma patients: A higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival

Published:2013-09 Issue:9 Volume:37 Page:1094-1099
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Song Xiao-Ning,Yang Jian-Zhu,Sun Li-Xia,Meng Jian-Bo,Zhang Jin-Qiao,Lv Hong-Yan,Kong Ling-Juan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. International uniform response criteria for multiple myeloma;Durie;Leukemia,2006

2. Role of the bone marrow microenvironment in multiple myeloma;Roodman;J Bone Miner Res,2002

3. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas;Kawano;Nature,1988

4. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications;Podar;Blood,2005

5. Insulin and insulin-like growth factor signalling in neoplasia;Pollak;Nat Rev Cancer,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma;Blood Advances;2023-07-27

2. High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients;Frontiers in Oncology;2022-08-31

3. Immunological Prognostic Factors in Multiple Myeloma;International Journal of Molecular Sciences;2021-03-30

4. Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels;Cytokine;2021-02

5. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer;International Reviews of Immunology;2020-11-04